PofoliaShared via Pofolia

Clinical Oral Investigations· 2026Q1

Salivary microbiome responses to chlorhexidine and Coriandrum sativum essential oil mouthwashes in patients with periodontitis in a randomized 2-week clinical trial

Alisa Kazarina, Anete Vaskevica, Dārta Elizabete Senkāne, Pawel Zayakin et al.

Short summary

A 2-week, 27-patient trial found that a Coriandrum sativum essential oil (CSEO) mouthwash did not significantly alter the salivary microbiome compared to water, while 0.12% chlorhexidine (CHX) caused significant changes in diversity and taxonomy.

AI-generated from the title and abstract; the full text is not read.

Key points

  • A 14-day trial compared CSEO, chlorhexidine (CHX), and water mouthwashes in 27 periodontitis patients.
  • CSEO mouthwash showed no statistically significant difference in salivary microbiome alpha diversity or species-level Bray-Curtis change compared to water.
  • CHX mouthwash significantly reduced species-level diversity and caused broad taxonomic restructuring of the salivary microbiome.
  • In vitro tests confirmed both CSEO and CHX inhibited Porphyromonas gingivalis, with CHX being more potent.

AI-generated from the title and abstract; the full text is not read.

Abstract

To compare the short-term salivary microbiome effects of a Coriandrum sativum essential oil (CSEO) mouthwash, chlorhexidine (CHX) as a benchmark comparator, and water in patients with periodontitis. In this randomized three-arm trial, participants with periodontitis rinsed twice daily for 14 days with water, CSEO, or 0.12% CHX. Preclinical anti- Porphyromonas gingivalis and fibroblast cytotoxicity assays informed CSEO concentration selection. Shotgun metagenomic sequencing was performed on 54 saliva libraries, two per participant, from 27 participants sampled at baseline and week 2 (H 2 O n = 9, CSEO n = 8, CHX n = 10). Alpha diversity, within-subject Bray-Curtis change, and differential abundance were analysed longitudinally. Both active agents inhibited P. gingivalis in vitro , with CHX showing greater potency. In the clinical trial, no statistically detectable difference between CSEO and water was observed for the primary species-level Bray-Curtis outcome (q = 0.413), alpha diversity (all q ≥ 0.259), or differential abundance. CHX showed greater species-level Bray-Curtis change than water (q = 0.020), lower species-level Simpson diversity (q = 0.014), and broad taxonomic restructuring. Under the tested formulation and exposure conditions, CSEO did not produce a statistically detectable group-level salivary microbiome shift relative to water. CHX provided a benchmark for broad ecological perturbation. The CSEO null finding does not exclude modest or heterogeneous effects in a larger cohort. No clinical benefit can be inferred from the absence of a detectable CSEO-associated microbiome shift. Larger studies integrating clinical, inflammatory, and direct functional outcomes are needed. ISRCTN79156900, retrospectively registered on 11 May 2026.

The authors' abstract, as published at the source. Clinical Oral Investigations, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Periodontics

PeriodonticsDentistry